Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | +3.44% | +3.04% | +16.31% |
05-06 | VYNE Therapeutics Says US FDA Clears its Investigational New Drug Application for Potential Autoimmune Treatment | MT |
04-04 | Transcript : VYNE Therapeutics Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.31% | 36.94M | |
+31.52% | 662B | |
+21.96% | 546B | |
-5.21% | 359B | |
+17.02% | 323B | |
+5.01% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Insider Trends: Insider Sales Add to 90-Day Trend at VYNE Therapeutics